Moreover, an HDAC inhibitor enhanced glucose metabolism and glycolysis in cardiomyocytes, increased cellular oxidative phosphorylation, and improved the function of myocardial mitochondria in diabetic cardiomyopathy [50]. The gene discussed is HDAC9; the disease is diabetic cardiomyopathy.